Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00379236 · ClinicalTrials.gov registry record · NA
A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee
A NA study, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 588
- Enrollment target
NCT00379236: Completed NA study, sponsored by Ferring Pharmaceuticals.
NCT00379236 is a NA study that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 588 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00379236, a NA study, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 588 participants
- Enrollment target
Study Summary
This multicenter, randomized, double-blind study will be performed in approximately 600 subjects with chronic idiopathic osteoarthritis (OA) of the knee. An open-label safety extension will follow.
Primary Outcome
The level of pain is estimated by the participant following a walk of 50 feet in length which is observed by the investigator. Pain estimates were evaluated on a 100 millimeter visual analog scale. A score of 0 millimeters means there was no pain observed; a score of 100 millimeters means extreme pain was observed.
Interventions
- DEVICE placebo
- DEVICE EUFLEXXA™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 588 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-05 |
| Phase | NA |
What the finished NCT00379236 record still lists
NCT00379236 is an interventional study that assigns participants to a tested intervention. The registered 588 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00379236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00379236 about?
NCT00379236 is a clinical study titled "A Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Painful Osteoarthritis of the Knee". This multicenter, randomized, double-blind study will be performed in approximately 600 subjects with chronic idiopathic osteoarthritis (OA) of the knee. An open-label safety extension will follow.
What is the current status of trial NCT00379236?
This trial is currently completed. It is a NA study. The enrollment target is 588 participants. The study started on 2006-10. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00379236?
The interventions under investigation include: placebo (DEVICE), EUFLEXXA™ (DEVICE).
Who is sponsoring clinical trial NCT00379236?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00379236's enrollment target sits among peer trials
588 176th of 2000 higher than 1,825 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06921603 · 588 participants · NA
POCUS-Guided Diuresis for Decompensated Heart Failure
- NCT06986954 · 588 participants
Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study
- NCT01365169 · 590 participants · NA
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- NCT03774758 · 590 participants
Biomarkers for Risk Stratification in Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia